Cheche Group Non-GAAP EPS of $0.02, revenue of $430M.
Share this article
Corporate
Score 25
Neutral
Cheche Group Non-GAAP EPS of $0.02, revenue of $430M
Apr 03, 2026 13:47 UTC
CHEC
Immediate term
Related Articles
Score 25
GT Biopharma enters agreement with University of Minnesota for phase 1 trial
Apr 07, 11:13
Score 45
Bearish
Leerink cuts BioNTech stock price target on drug trial concerns
Apr 07, 11:11
Score 25
Bullish
Leerink Partners initiates Sutro Biopharma stock with outperform rating
Apr 07, 11:11
Score 25
Form 8K Kiora Pharmaceuticals Inc For: 7 April
Apr 07, 11:10
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.